{"id":"W4398781462","doi":"10.1017/cjn.2024.74","title":"A.1 Repurposing Ambroxol as a disease-modifying treatment for Parkinson’s disease dementia: A phase 2, randomized, double blind placebo-controlled trial","year":2024,"lang":"en","type":"article","venue":"Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Vancouver Biotech (Canada)","funders":"","keywords":"Ambroxol; Placebo; Medicine; Dementia; Adverse effect; Internal medicine; Disease; Anesthesia; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001210783,0.001927166,0.00310526,0.0006722875,0.000549918,0.001222344,0.001054353,0.002903722,0.01159247],"category_scores_gemma":[0.001105532,0.0007848334,0.00181408,0.0003851562,0.001027567,0.001202165,0.0003550062,0.002494037,0.001843229],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005170432,"about_ca_system_score_gemma":0.0008753801,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007632123,"about_ca_topic_score_gemma":0.001533823,"domain_scores_codex":[0.9995053,0.0002092677,0.00003631094,0.0001138157,0.00004846196,0.00008681632],"domain_scores_gemma":[0.9995126,0.0001150504,0.0001301747,0.00003140813,0.00005068017,0.0001601319],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9711516,0.006024139,0.0002472478,0.001533022,0.0007934623,0.00005883751,0.00004175373,0.0001597811,0.004682812,0.0001126856,0.001092829,0.01410178],"study_design_scores_gemma":[0.9629248,0.03524107,0.0006828298,0.00004286327,0.0002136841,0.00002736868,0.00000937962,0.0001705865,0.000202257,0.00006758977,0.0004083918,0.000009101206],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9583131,0.01985696,0.001297903,0.001516196,0.00109438,0.01045532,0.003149404,0.0004279271,0.003888742],"genre_scores_gemma":[0.9607655,0.009642934,0.003036807,0.002853403,0.001055853,0.01317797,0.002281611,0.00004574256,0.007140177],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01159247,"threshold_uncertainty_score":0.03878069,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0647321998356741,"score_gpt":0.3458826779944765,"score_spread":0.2811504781588025,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}